糖尿病黄斑水肿的诊断和治疗进展  

Research progress in diagnosis and treatment of diabetic macular edema

作　　者：邵毅[1] 李乐妍 魏红 SHAO Yi;LI Leyan;WEI Hong(Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China)

机构地区：[1]南昌大学第一附属医院眼科,江西省南昌市330006

出　　处：《眼科新进展》2022年第11期841-846,共6页Recent Advances in Ophthalmology

基　　金：中央引导地方科技发展基金(编号:20211ZDG02003);江西省重点研发项目(编号:20181BBG70004,20203BBG73059)。

摘　　要：糖尿病黄斑水肿(DME)的发病率正逐渐上升,其作为导致糖尿病患者视力不可逆丧失的主要原因,一直受到医学研究者的关注。目前,在应用诸如光学相干断层扫描和抗血管内皮生长因子等针对DME的诊疗方法的同时,多种新兴的解决方案正在被研发。因此,本文将对现有DME的诊断和治疗方案进行总结讨论,以期为未来DME诊疗标准的统一奠定基础。The incidence rate of diabetic macular edema(DME)is rising.As the main cause for irreversible loss of vision in diabetic patients,DME has been getting more attention of medical researchers.In addition to existing optical coherence tomography and anti-vascular endothelial growth factor therapies for DME,a variety of new solutions are being developed.This article summarizes and discusses current diagnostic and therapeutic methods for DME,laying a foundation for its unified diagnosis and treatment in the future.

关 键 词：糖尿病黄斑水肿 糖尿病视网膜病变 光学相干断层扫描 荧光素眼底血管造影 

分 类 号：R777.34[医药卫生—眼科]